Posted by
Many Advanced Colon Cancers Were ‘Born’ Ready to Spread

Many Advanced Colon Cancers Were ‘Born’ Ready to Spread

By Amy NortonHealthDay Reporter Latest Cancer News TUESDAY, June 18, 2019 (HealthDay News) — In most patients with metastatic colon cancer, the disease may have begun spreading throughout the body very early on — when the original tumor was no bigger than a poppy seed, a new study suggests. Metastatic refers to the most advanced […]

Posted by
Yogurt Might Help Men Avoid Colon Cancer: Study

Yogurt Might Help Men Avoid Colon Cancer: Study

By Steven ReinbergHealthDay Reporter Latest Cancer News TUESDAY, June 18, 2019 (HealthDay News) — Yogurt is a healthy food, and it may also be a cancer fighter, a new study suggests. Men who had two or more servings of yogurt a week had a 26% lower risk of developing precancerous growths in their colon, a […]

Posted by
Your Drinking Water May Harbor Cancer-Causing Nitrate: Study

Your Drinking Water May Harbor Cancer-Causing Nitrate: Study

By Steven ReinbergHealthDay Reporter Latest Cancer News WEDNESDAY, June 12, 2019 (HealthDay News) — Millions of tons of nitrate from industrial farming find their way into America’s drinking water each year, causing thousands of cases of cancer and other health problems, an environmental advocacy group says. In a new report, researchers from the Environmental Working […]

Posted by
No Needle Prick: Laser-Based Test Hunts Stray Melanoma Cells in Blood

No Needle Prick: Laser-Based Test Hunts Stray Melanoma Cells in Blood

By Amy NortonHealthDay Reporter Latest Cancer News WEDNESDAY, June 12, 2019 (HealthDay News) — Monitoring a melanoma patient’s progress is challenging. But a laser-based test might allow doctors to quickly screen the patient’s blood to spot tumor cells roaming the body, a preliminary study suggests. Those cells, known as circulating tumor cells, are “shed” from […]

Posted by
Adenoid Cystic Carcinoma (ACC)

Adenoid Cystic Carcinoma (ACC)

Adenoid Cystic Carcinoma Symptom Paralysis Paralysis is the loss or impairment of voluntary muscular power. Paralysis can result from either diseases involving changes in the makeup of nervous or muscular tissue or those that are the result of metabolic disturbances that interfere with the function of nerves or muscles. Depending upon the cause, paralysis may […]

Posted by
Scared Safe: Pics of Sun’s Damage to Face Boost Sunscreen Use

Scared Safe: Pics of Sun’s Damage to Face Boost Sunscreen Use

Latest Cancer News WEDNESDAY, June 12, 2019 (HealthDay News) — When all else fails, fear may motivate people to protect themselves from the sun. Researchers found that a photo of a mole being removed and visuals of skin damage did the trick. Study volunteers were shown photos taken using a VISIA UV camera system. These […]

Posted by
Cancer Survivors Predicted to Top 22 Million by 2030

Cancer Survivors Predicted to Top 22 Million by 2030

Latest Cancer News TUESDAY, June 11, 2019 (HealthDay News) — More Americans are surviving cancer, and their numbers could top 22 million in another decade, the American Cancer Society says. Currently, thanks to better screening and treatment, more than 17 million Americans who had cancer remain alive, the society said in a new report. While […]

Posted by
Chemoimmunotherapy Regimen Approved to Treat DLBCL

Chemoimmunotherapy Regimen Approved to Treat DLBCL

Latest Cancer News TUESDAY, June 11, 2019 (HealthDay News) — Polivy (polatuzumab vedotin-piiq), a novel antibody-drug conjugate, received approval to treat patients with diffuse large B-cell lymphoma (DLBCL) in combination with bendamustine and rituximab, the U.S. Food and Drug Administration announced today. The combination was approved for patients whose disease has progressed or returned after […]

Posted by
Ibrance (palbociclib)

Ibrance (palbociclib)

What drugs interact with Ibrance? Palbociclib is primarily metabolized by CYP3A and sulfotransferase (SULT) enzyme SULT2A1. In vivo, palbociclib is a time-dependent inhibitor of CYP3A. Effect of CYP3A Inhibitors Coadministration of a strong CYP3A inhibitor (itraconazole) increased the plasma exposure of palbociclib in healthy subjects by 87%. Avoid concomitant use of strong CYP3A inhibitors (e.g., […]